BMO Capital analyst Evan Seigerman downgraded Replimune Group (NASDAQ: REPL) from Market Perform to Underperform with a price target of ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments Downgrades